Company: NCEL
Filing Date: 2025-02-05
Form Type: F-3
Source: 0001213900-25-010223
Chunk: 0

Company: NewcelX Ltd.
Filing Date: 2025-02-05
Form: F-3
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on February 4, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM F-3

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

NLS Pharmaceutics Ltd.

(Exact name of registrant as specified in its charter)</div>

| Switzerland                    |     |                         3841 |     | Not                   
 Applicable            |
| (State or other jurisdiction   
 of                             
 incorporation or organization) |     | -Primary Standard Industrial 
   Classification Code Number |     | -I.R.S. Employer      
 Identification Number |

|                                       |     | Puglisi &                   
 Associates                  |
| The Circle 6                          |     | 850 Library Ave., Suite     
 204                         |
| 8058 Zurich, Switzerland              |     | Newark, DE 19711            |
| Tel:                                  
 +41.44.512.2150                       |     | Tel:                        
 (302) 738-6680              |
| (Address, including zip               
 code, and telephone number, including |     | (Name, address, including   
 zip code, and telephone     |
| area code, of registrant’s            
 principal executive offices)          |     | number, including area      
 code, of agent for service) |

<div align='center'>Copies to:</div>

| Oded Har-Even,              
 Esq.                        |     | Dr. Matthias               
 Courvoisier                |
| Howard E. Berkenblit,       
 Esq.                        |     | Baker McKenzie Switzerland 
 AG                         |
| Ron Ben-Bassat, Esq.        |     | Holbeinstrasse 30          |
| Sullivan & Worcester        
 LLP                         |     | Zurich, Switzerland 8034   |
| 1251 Avenue of the Americas |     | Tel: +41 44 384 14 14      |
| New York, NY 10020          |     |                            |
| Tel: (212) 660-3000         |     |                            |

Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date hereof.

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box